Spearhead Capital Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Spearhead Capital Advisors's RGEN Position: Q3 2022 in Review
Spearhead Capital Advisors sold out of Repligen (RGEN) in Q3 2022, closing a stake of 1,365 shares — an estimated $222K sold.
Spearhead Capital Advisors first reported a position in RGEN in Q2 2020 and held it in 9 quarters. The position peaked at $605K in Q3 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.
- Spearhead Capital Advisors reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
- Spearhead Capital Advisors sold 1,365 Repligen shares in Q3 2022, an estimated $222K.
- Spearhead Capital Advisors first reported a position in Repligen in Q2 2020 and held it in 9 quarters.
- Spearhead Capital Advisors's Repligen position peaked at $605K in Q3 2021.
- 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.
Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.